BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Vitae Pharma Announces Positive Top-Line Results From Initial Phase 1 Study Of First-In-Class Roryt Inhibitor VTP-43742 In Autoimmune Disorders

  September 9, 2015

   · 

  6 min read
• Business

  Evotec AG, Pfizer Strike Tissue Fibrosis Deal

  September 9, 2015

   · 

  4 min read
• Business

  Dow AgroSciences LLC Announces License Agreement With Critical Path Services

  September 9, 2015

   · 

  3 min read
• Drug Development

  Flexion Tanks as Lead Drug Flunks Pivotal Phase IIb Clinical Trial

  September 9, 2015

   · 

  6 min read
• Drug Development

  TetraPhase Sinks 80% Premarket as Eravacycline Fails to Meet Phase III Trial Goals

  September 9, 2015

   · 

  9 min read
• Drug Development

  GlaxoSmithKline And Theravance Announce Results From The SUMMIT COPD CV Survival Study

  September 9, 2015

   · 

  19 min read
• Drug Development

  FDA Grants Priority Review To Takeda’s Ixazomib For Patients With Relapsed/Refractory Multiple Myeloma

  September 9, 2015

   · 

  5 min read
• Drug Development

  Celsion Completes Integration Of EGEN And Outlines Clinical Development Plan For GEN-1 IL-12 Immunotherapy Program

  September 9, 2015

   · 

  6 min read
• Harlan Laboratories, Inc. Release: Contract Research & Toxicology

  September 9, 2015

   · 

  14 min read
• Genetown

  Tal Medical Enrolls First Patient In Dose Optimization Study For Innovative Investigational Therapy To Treat Depression And Other Neuropsychiatric Disorders

  September 9, 2015

   · 

  5 min read